Laura Bernabei

Here below are the publications (1) participated by Laura Bernabei along with Chiara Falzarano (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma

Journal of Experimental & Clinical Cancer Research, 11 novembre 2021

Facts & figures

Laura Bernabei has coordinated or participated in 2 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 11 elements tag cloud:

11q24.3 gain (1) ASB2 (1) diffuse large B-cell lymphoma (DLBCL) (1) DNA-biosensor (1) fluorescence (1) microfluidic (1) NFKB pathway (1) RNA extraction (1) SARS-CoV-2 detection (1) silica slide (1) transcription factor FLI1 (1)

Laura Bernabei has coordinated or participated in 2 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 2 scientific journals:

Biosensors and Bioelectronics: X (1) Journal of Experimental & Clinical Cancer Research (1)

Laura Bernabei has coordinated or participated in 2 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 18 co-authors being active in Ticino:

Francesco Bertoni (2) Luciano Cascione (2) Valdemar Priebe (1) Michela Dall’Angelo (1) Chiara Falzarano (1) Stefano Marocco (1) Alberto Jesus Arribas (1) Jacopo Pagnoncelli (1) Daniele Nicolis (1) Agatino Christian Tavilla (1) Sara Napoli (1) Giulio Sartori (1) Elaine Yee Lin Chung (1) Andrea Rinaldi (1) Roberto Robortella (1) Afua Adjeiwaa Mensah (1) Igor Stefanini (1) Chiara Tarantelli (1)

Laura Bernabei has coordinated or participated in 2 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 17 most frequently used terms (excluding 14 not relevant terms) are here listed:

L.B. WORD CLOUD asb (1) fli (1) sustains (1) nf (1) pathway (1) germinal (1) center-derived (1) b-cell (1) lymphoma (1) dna (1) biosensors-based (1) microfluidic (1) attomolar (1) real-time (1) unamplified (1) sars-cov (1) virus (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 14 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)

Il mondo delle startup

Laura Bernabei has participated - as a whole - in 2 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Chiara Falzarano

1) ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma

Laura Bernabei has participated - as a whole - in 2 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Chiara Falzarano